SERVIER LABORATORIES (IRELAND) LIMITED

Servier Laboratories (Ireland) Limited is the Irish arm of the international Servier Group, a research-driven pharmaceutical organisation dedicated to developing innovative medicines for patients. Drawing on more than 70 years of experience, Servier focuses on three therapeutic areas - oncology, neurology and rare diseases - and works closely with patients throughout the drug-development cycle to ensure treatments are both scientifically advanced and aligned with real-world quality-of-life needs.

In addition to its core drug pipeline, Servier is expanding its research capacity through strategic partnerships and the launch of Servier Ventures, a dedicated venture-capital fund that accelerates breakthrough innovations. Recent collaborations have brought promising candidates such as darovasertib for uveal melanoma and a potential therapy for fragile-X syndrome into the company's portfolio, underscoring its commitment to tackling unmet medical needs.

Based in Ireland, Servier serves patients, healthcare partners and the wider community by fostering value-sharing relationships, promoting responsible logistics and championing social responsibility across all its activities.